How is Carbamazepine Intravenous Route dosed?
The intravenous route of carbamazepine is used as a replacement therapy for oral carbamazepine to treat adults with certain types of seizures (epilepsy). The dosage instructions should be followed as provided by the doctor, considering individual factors such as age, weight, medical history, and current medications.
What medications are contraindication with Carbamazepine Intravenous Route?
Carbamazepine injection should not be used with certain medications as it may increase the risk of side effects. The medications that should not be used with carbamazepine intravenous route include: Abemaciclib, Abiraterone Acetate, Acalabrutinib, Acetazolamide, Adagrasib, Adenosine, Afatinib, Alfentanil, Almotriptan, Alpelisib, Alprazolam, Amodiaquine, Amphetamine, Amprenavir, Apixaban, Apremilast, Aprepitant, Aripiprazole, Artesunate, Atogepant, Avacopan, Avapritinib, Axitinib, Bedaquiline, Belumosudil, Bendamustine, Benzhydrocodone, Benzphetamine, Berotralstat, Betrixaban, Bictegravir, Bortezomib, Bosutinib, Brexpiprazole, Brigatinib, Buprenorphine, Bupropion, Butorphanol, Cabozantinib, Calcifediol, Cannabidiol, Capmatinib, Cariprazine, Cenobamate, Ceritinib, Chloroquine, Darunavir, Darunavir/Cobicistat, Diroximel Fumarate, Dolutegravir, Doravirine, Efavirenz, Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, Emtricitabine/Tenofovir Disoproxil Fumarate, Encorafenib/Braftovi, Enzalutamide, Eribulin, Erlotinib, Everolimus, Fingolimod, Fluocinolone, Fluocinonide, Fluoxetine, Fluphenazine, Fluoxymesterone, Fluticasone, Fluvastatin, Fulvestrant, Gefitinib, Gilteritinib, Glecaprevir/Pibrentasvir, Glipizide.
How is Carbamazepine Intravenous Route administered?
Carbamazepine intravenous route is administered by a nurse or other trained health professional in a hospital setting. The medicine is given through a needle placed in one of the veins.
What are common precautions when taking Carbamazepine Intravenous Route?
Common precautions when taking carbamazepine intravenous route include:
- Allergies: Inform your doctor if you have any allergies or have had allergic reactions to carbamazepine or any other medicines in the past.
- Pediatric Use: The safety and efficacy of carbamazepine injection in children have not been established, so its use in pediatric patients should be carefully considered.
- Geriatric Use: Elderly patients may be more susceptible to hyponatremia (low sodium levels in the blood), which may require caution when using carbamazepine injection.
- Monoamine Oxidase Inhibitors (MAOIs): Do not use carbamazepine together with MAOIs or during the first 14 days after stopping an MAOI. Examples of MAOIs include isocarboxazid, phenelzine, selegiline, and tranylcypromine.
- Serious Skin Reactions: Inform your doctor immediately if you experience any severe skin reactions, such as blistering, peeling, or loose skin, red skin lesions, severe acne or skin rash, sores or ulcers on the skin, fever, or chills while using carbamazepine.
- Blood Problems: Watch for symptoms of a serious blood problem, such as fever, sore throat, rash, ulcers in the mouth, nosebleeds, bleeding gums, swollen glands, or small red or purple spots on the skin.
- Drug Interactions: Let your doctor know if you are taking any other medications, including boceprevir, delavirdine, and nefazodone, as carbamazepine may interact with these drugs. It is essential to follow your doctor's instructions and discuss any concerns you may have regarding the use of carbamazepine intravenous route.